Are Ketamine Clinics Paving the Way for Legal Psychedelic Therapy?

This DoubleBlind article explores the growth of ketamine clinics in the United States and asks whether they are paving the way for legal psychedelic therapy. It explains how ketamine is currently used in clinical settings, including differences between infusion-only clinics and programs that combine infusions with psychotherapy. The piece also looks at the likely future regulation of MDMA and psilocybin therapy, including the need for official FDA protocols. It discusses how clinics may prepare for expanded psychedelic services by building infrastructure, training staff, and blending approaches from clinical research and psychedelic therapy. This content is relevant for readers interested in psychedelic-assisted therapy, clinic models, regulation, and the practical questions surrounding access and affordability.